Inhibition of Interleukin-10 by the Immunomodulator AS101 Reduces Mesangial Cell Proliferation in Experimental Mesangioproliferative Glomerulonephritis
Open Access
- 1 June 2004
- journal article
- Published by Elsevier
- Vol. 279 (23), 24724-24732
- https://doi.org/10.1074/jbc.m312006200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritisClinical and Experimental Immunology, 2002
- Gas6 Induces Mesangial Cell Proliferation via Latent Transcription Factor STAT3Published by Elsevier ,2001
- Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promotersCell Death & Differentiation, 2000
- The Immunomodulator AS101 Restores TH1Type of Response Suppressed byBabesia rodhainiin BALB/c MiceCellular Immunology, 1998
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Predominance of TH1 Response in Tumor-Bearing Mice and Cancer Patients Treated With AS 101JNCI Journal of the National Cancer Institute, 1996
- Loss of Tumorigenicity and Increased Immunogenicity Induced by Interleukin-10 Gene Transfer in B16 Melanoma CellsHuman Gene Therapy, 1996
- Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.Journal of Clinical Investigation, 1993
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- Interleukin 6 is an autocrine growth factor for mesangial cellsKidney International, 1990